{"entity":{"iso2":"BZ","iso3":"BLZ","name":"Belize","slug":"belize"},"indicator":{"licence":"CC BY 4.0 (World Bank Open Data)","slug":"access-to-anti-retroviral-drugs-female-percent","source":"UNAIDS estimates","source_url":"https://data.worldbank.org/indicator/SH.HIV.ARTC.FE.ZS","title":"Access to anti-retroviral drugs, female (%)","unit":"%"},"observations":[{"date":"2000-01-01","value":0.0},{"date":"2001-01-01","value":0.0},{"date":"2002-01-01","value":2.0},{"date":"2003-01-01","value":6.0},{"date":"2004-01-01","value":5.0},{"date":"2005-01-01","value":9.0},{"date":"2006-01-01","value":11.0},{"date":"2007-01-01","value":14.0},{"date":"2008-01-01","value":18.0},{"date":"2009-01-01","value":26.0},{"date":"2010-01-01","value":28.0},{"date":"2011-01-01","value":34.0},{"date":"2012-01-01","value":34.0},{"date":"2013-01-01","value":36.0},{"date":"2014-01-01","value":36.0},{"date":"2015-01-01","value":39.0},{"date":"2016-01-01","value":41.0},{"date":"2017-01-01","value":42.0},{"date":"2018-01-01","value":44.0},{"date":"2019-01-01","value":45.0},{"date":"2020-01-01","value":45.0},{"date":"2021-01-01","value":46.0},{"date":"2022-01-01","value":48.0},{"date":"2023-01-01","value":49.0},{"date":"2024-01-01","value":51.0}],"summary":{"latest_period":"2024-01-01","latest_value":51.0,"max":51.0,"mean":28.36,"min":0.0,"of":141,"rank":118,"trend":"volatile"}}